Literature DB >> 2125304

Successful treatment of massive pulmonary embolism with recombinant tissue type plasminogen activator (rt-PA) in a pregnant woman with intact gravidity and preterm labour.

T Flossdorf1, M Breulmann, H B Hopf.   

Abstract

We report a patient with massive pulmonary embolism and circulatory shock during pregnancy (31st gestational week) and preterm labour who has been successfully treated with recombinant tissue type plasminogen activator. Thrombolysis was performed using 10 mg.h-1 over 4 h followed by 2 mg.h-1 for 1 h 30 min resulting in complete resolution of cardio-respiratory symptoms. Except for slight bleeding from one puncture site no complications occurred. At 48 h after the end of thrombolytic therapy the patient was delivered spontaneously of a male preterm healthy infant. The relevance of this new thrombolytic agent in the treatment of massive life-threatening pulmonary embolism during pregnancy is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125304     DOI: 10.1007/bf01711225

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  10 in total

1.  [A successful lytic treatment of a perioperative pulmonary embolism necessitating resuscitation using recombinant tissue-type plasminogen activator].

Authors:  H B Hopf; B Grote; H Becker; M Breulmann
Journal:  Anaesthesist       Date:  1990-01       Impact factor: 1.041

2.  Thrombolytic therapy in canine pulmonary embolism. Comparative effects of urokinase and recombinant tissue plasminogen activator.

Authors:  R M Prewitt; C Hoy; A Kong; S A Gu; D Greenberg; R Cook; S M Chan; J Ducas
Journal:  Am Rev Respir Dis       Date:  1990-02

3.  Thrombolytic therapy for pulmonary embolism in pregnancy: a case report.

Authors:  G L Delclos; F Davila
Journal:  Am J Obstet Gynecol       Date:  1986-08       Impact factor: 8.661

Review 4.  Tissue plasminogen activator.

Authors:  J Loscalzo; E Braunwald
Journal:  N Engl J Med       Date:  1988-10-06       Impact factor: 91.245

5.  Pulmonary embolectomy: its place in the management of pulmonary embolism.

Authors:  H H Gray; G A Miller; M Paneth
Journal:  Lancet       Date:  1988-06-25       Impact factor: 79.321

6.  Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism.

Authors:  M Verstraete; G A Miller; H Bounameaux; B Charbonnier; J P Colle; G Lecorf; G A Marbet; P Mombaerts; C G Olsson
Journal:  Circulation       Date:  1988-02       Impact factor: 29.690

7.  Massive pulmonary embolism during pregnancy treated with streptokinase.

Authors:  D R McTaggart; T G Ingram
Journal:  Med J Aust       Date:  1977 Jan 1-8       Impact factor: 7.738

8.  Pulmonary embolectomy, heparin, and streptokinase: their place in the treatment of acute massive pulmonary embolism.

Authors:  G A Miller; R J Hall; M Paneth
Journal:  Am Heart J       Date:  1977-05       Impact factor: 4.749

9.  [Physiopathology and clinical aspects of pulmonary embolism].

Authors:  B E Strauer
Journal:  Internist (Berl)       Date:  1984-02       Impact factor: 0.743

10.  Thromboembolic complications of pregnancy.

Authors:  J C Bolan
Journal:  Clin Obstet Gynecol       Date:  1983-12       Impact factor: 2.190

  10 in total
  2 in total

Review 1.  Thrombolytic therapy in pregnancy.

Authors:  Georg Leonhardt; Charly Gaul; Hubert H Nietsch; Michael Buerke; Ekkehard Schleussner
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

2.  The use of thrombolytic therapy in pregnancy.

Authors:  Eric J Gartman
Journal:  Obstet Med       Date:  2013-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.